359 related articles for article (PubMed ID: 30721373)
1. Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment.
Jain A; Sharma G; Thakur K; Raza K; Shivhare US; Ghoshal G; Katare OP
AAPS PharmSciTech; 2019 Feb; 20(3):100. PubMed ID: 30721373
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer.
Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP
Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643
[TBL] [Abstract][Full Text] [Related]
3. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E TPGS Emulsified Vinorelbine Bitartrate Loaded Solid Lipid Nanoparticles (SLN): Formulation Development, Optimization and In vitro Characterization.
Maurya L; Singh S; Rajamanickam VM; Narayan G
Curr Drug Deliv; 2018; 15(8):1135-1145. PubMed ID: 29629662
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Oral Absorption of All-trans Retinoic Acid upon Encapsulation in Solid Lipid Nanoparticles.
Kumar M; Sharma G; Singla D; Singh S; Kakkar V; Gulati JS; Kaur IP
Pharm Nanotechnol; 2020; 8(6):495-510. PubMed ID: 33115399
[TBL] [Abstract][Full Text] [Related]
6. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
[TBL] [Abstract][Full Text] [Related]
7. Development of vorinostat-loaded solid lipid nanoparticles to enhance pharmacokinetics and efficacy against multidrug-resistant cancer cells.
Tran TH; Ramasamy T; Truong DH; Shin BS; Choi HG; Yong CS; Kim JO
Pharm Res; 2014 Aug; 31(8):1978-88. PubMed ID: 24562809
[TBL] [Abstract][Full Text] [Related]
8. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
[TBL] [Abstract][Full Text] [Related]
9. Beta carotene-loaded zein nanoparticles to improve the biopharmaceutical attributes and to abolish the toxicity of methotrexate: a preclinical study for breast cancer.
Jain A; Sharma G; Kushwah V; Ghoshal G; Jain A; Singh B; Shivhare US; Jain S; Katare OP
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):402-412. PubMed ID: 29361842
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability.
Sun J; Bi C; Chan HM; Sun S; Zhang Q; Zheng Y
Colloids Surf B Biointerfaces; 2013 Nov; 111():367-75. PubMed ID: 23856543
[TBL] [Abstract][Full Text] [Related]
11. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
Thirupathi G; Swetha E; Narendar D
Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
[TBL] [Abstract][Full Text] [Related]
12. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
13. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery.
Feng H; Zhu Y; Fu Z; Li D
Chem Biol Drug Des; 2017 Nov; 90(5):867-872. PubMed ID: 28432812
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
16. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles.
Trivino A; Gumireddy A; Chauhan H
AAPS PharmSciTech; 2019 Jan; 20(2):46. PubMed ID: 30617602
[TBL] [Abstract][Full Text] [Related]
17. Lycopene loaded whey protein isolate nanoparticles: An innovative endeavor for enhanced bioavailability of lycopene and anti-cancer activity.
Jain A; Sharma G; Ghoshal G; Kesharwani P; Singh B; Shivhare US; Katare OP
Int J Pharm; 2018 Jul; 546(1-2):97-105. PubMed ID: 29715533
[TBL] [Abstract][Full Text] [Related]
18. Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability.
Pan Y; Tikekar RV; Nitin N
Int J Pharm; 2016 Sep; 511(1):322-330. PubMed ID: 27418566
[TBL] [Abstract][Full Text] [Related]
19. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene-loaded SLNs with enhanced biopharmaceutical potential: QbD-steered development, in vitro evaluation, in vivo pharmacokinetics, and IVIVC.
Jain A; Sharma T; Kumar R; Katare OP; Singh B
Drug Deliv Transl Res; 2022 May; 12(5):1136-1160. PubMed ID: 33966178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
